|
🐜
|
Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression
23 auth.
Guohe Song,
Yang Shi,
Meiying Zhang,
S. Goswami,
S. Afridi,
Lu Meng,
Jiaqiang Ma,
Yi Chen,
Youpei Lin,
Juan Zhang,
...
Yuming Liu,
Zijie Jin,
Shuaixi Yang,
D. Rao,
Shu Zhang,
A. Ke,
Xiaoying Wang,
Ya Cao,
Jian Zhou,
Jia Fan,
Xiaoming Zhang,
Ruibin Xi,
Q. Gao
|
6 |
2020 |
6
🐜
|
|
🐜
|
Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma
27 auth.
Guohe Song,
Yang Shi,
Lu Meng,
Jiaqiang Ma,
Siyuan Huang,
Juan Zhang,
Yingcheng Wu,
Jiaxin Li,
Youpei Lin,
Shuaixi Yang,
D. Rao,
Yifei Cheng,
Jian Lin,
S. Ji,
Yuming Liu,
...
Shan Jiang,
Xiaoliang Wang,
Shu Zhang,
A. Ke,
Xiaoying Wang,
Yanlong Cao,
Yuan Ji,
Jian Zhou,
Jia Fan,
Xiaoming Zhang,
Ruibin Xi,
Q. Gao
|
6 |
2022 |
6
🐜
|
|
🐜
|
IL-17A Secreted from Lymphatic Endothelial Cells Promotes Tumorigenesis by Up-regulation of PD-L1 in Hepatoma Stem Cells.
12 auth.
Yuanyan Wei,
Danfang Shi,
Ziwei Liang,
Yuming Liu,
Yinan Li,
Yang Xing,
...
Weitao Liu,
Zhilong Ai,
Jianhui Zhuang,
Xiaoning Chen,
Q. Gao,
Jianhai Jiang
|
5 |
2019 |
5
🐜
|
|
🐜
|
Geospatial immune heterogeneity reflects the diverse tumor-immune interactions in intrahepatic cholangiocarcinoma.
23 auth.
Youpei Lin,
Lihua Peng,
Liangqing Dong,
Dongbing Liu,
Jiaqiang Ma,
Jian Lin,
Xiaofang Chen,
Penghui Lin,
Guohe Song,
Mao Zhang,
...
Yuming Liu,
Junhua Rao,
Chen Wei,
Ye Lu,
Shu Zhang,
Guangyu Ding,
Z. Peng,
Haorong Lu,
Xiaoying Wang,
Jian Zhou,
Jia Fan,
Kui Wu,
Qiang Gao
|
5 |
2022 |
5
🐜
|
|
🐜
|
Autoantibody signature in hepatocellular carcinoma using seromics
18 auth.
Shu Zhang,
Yuming Liu,
Jing Chen,
H. Shu,
Siyun Shen,
Yin Li,
Xinyuan Lu,
Xinyi Cao,
Liangqing Dong,
Jieyi Shi,
...
Ya Cao,
Xiaoying Wang,
Jian Zhou,
Yin‐kun Liu,
Lei Chen,
Jia Fan,
Guangyu Ding,
Q. Gao
|
5 |
2020 |
5
🐜
|
|
🐜
|
The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome
14 auth.
Bohao Zheng,
Jiaqiang Ma,
Lingyu Tian,
Liangqing Dong,
Guohe Song,
Jiaomeng Pan,
Yuming Liu,
Shuaixi Yang,
Xiao-Ying Wang,
Xiaoming Zhang,
...
Jian Zhou,
Jia Fan,
Jieyi Shi,
Q. Gao
|
4 |
2020 |
4
🐜
|
|
🐜
|
Publisher Correction: Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma
27 auth.
Guohe Song,
Yang Shi,
Lu Meng,
Jiaqiang Ma,
Siyuan Huang,
Juan Zhang,
Yingcheng Wu,
Jiaxin Li,
Youpei Lin,
Shuaixi Yang,
D. Rao,
Yifei Cheng,
Jian Lin,
S. Ji,
Yuming Liu,
...
Shanxi Jiang,
Xiaoliang Wang,
Shu Zhang,
A. Ke,
Xiaoying Wang,
Yanlong Cao,
Yuan Ji,
Jian Zhou,
Jia Fan,
Xiaoming Zhang,
Ruibin Xi,
Q. Gao
|
3 |
2022 |
3
🐜
|
|
🐜
|
SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis.
9 auth.
Fanghua Chen,
Ling Aye,
Lei Yu,
Longzi Liu,
Yuming Liu,
Youpei Lin,
...
Dongmei Gao,
Qiang Gao,
Shu Zhang
|
2 |
2023 |
2
🐜
|
